Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, January 05, 2022
Emmes, a global, full-service Clinical Research Organization (CRO) announced that it has acquired Institut Dr. Schauerte, a CRO headquartered in Munich, Germany. Founded in 1990, Institut Dr. Schauerte is a full-service, technology-oriented CRO that ...
read more
Wednesday, November 17, 2021
Emmes, a global, full-service Clinical Research Organization dedicated to supporting the advancement of public health and biopharmaceutical innovation, announced a partnership with MedGenome aimed at accelerating breakthrough treatments, powered by ...
read more
Emmes announced that it provided the data and statistical analysis support for the Phase 1 clinical trial of the investigational COVID-19 vaccine mRNA-1273.
read more
Monday, February 08, 2021
Emmes announced progress in its role as Data Coordinating Center for studies conducted under the Best Pharmaceuticals for Children Act (BPCA).
read more
Wednesday, September 20, 2023
Emmes, a global, full-service Clinical Research Organization (CRO) announced that Peter Ronco has been named Chief Executive Officer.
read more
Emmes announced that Kathleen Wolf has joined the company as vice president of clinical operations.
read more
Thursday, September 05, 2024
Emmes has been selected by the National Institutes of Health's (NIH) NIDA [National Institute of Drug Abuse] to support their Clinical Trials Network (CTN) for a multi-task, IDIQ contract.
read more
Emmes announced the award of eight new task order contract awards associated with the Helping to End Addiction Long-term Initiative, known as the NIH HEAL Initiative.
read more
Emmes Group, a specialty tech-enabled global contract research organization (CRO), announced a multi-year strategic partnership with Miimansa AI. A critical part of the partnership, aimed at revolutionizing clinical research at Emmes, is the ...
read more
Emmes – a global, full-service Contract Research Organization (CRO) will introduce to market its third generation version of Advantage eClinical at Society for Clinical Trials (SCT) in San Diego, May 15th – 18th.
read more
Friday, December 09, 2022
Emmes announced the creation of a dedicated center to enhance Emmes’ legacy and depth in cell and gene therapy research.
read more
EmpiraMed announced it is collaborating with LUNGevity Foundation to gather patient reported outcomes (PROs) from lung cancer patients and their caregivers in a real-world setting.
read more
Wednesday, February 20, 2019
Empire Genomics announced the appointments of Andy Watson as CEO and Anthony Scarpello to Chief Commercialization Officer, and the opening of its new headquarters in Williamsville, NY.
read more
EmpowerPharm Inc. is delighted to announce the outcome of their Phase 2 clinical trial assessing the dose finding, efficacy, safety, and tolerability of Cannabidiol (CBD) drug product for Social Anxiety Disorder (SAD).
read more
Emulate, Inc. has announced a strategic collaboration with Laboratory Corporation of America® Holdings (LabCorp®) that seeks to integrate Emulate’s Organs-on-Chips technology into preclinical drug evaluation and testing services.
read more